AQR Arbitrage’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

AQR Arbitrage’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-190,800	Closed	-$1.95M	–	1065
2023 Q1	$1.95M	Sell	190,800 -9,200	-5%	-$93.4K	0.06%	330
2022 Q4	$2.01M	Hold	200,000	–	–	0.05%	411
2022 Q3	$1.97M	Hold	200,000	–	–	0.04%	495
2022 Q2	$1.95M	Hold	200,000	–	–	0.04%	462
2022 Q1	$1.95M	Hold	200,000	–	–	0.05%	376
2021 Q4	$1.93M	Hold	200,000	–	–	0.05%	426
2021 Q3	$1.93M	Buy	+200,000	New	+$1.95M	0.06%	286

AQR Arbitrage's ORIA Position: Q2 2023 in Review

AQR Arbitrage sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 190,800 shares — an estimated $1.95M sold.

AQR Arbitrage first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $2.01M in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

AQR Arbitrage reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
AQR Arbitrage sold 190,800 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.95M.
AQR Arbitrage first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
AQR Arbitrage's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $2.01M in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.